← Eichor
Study identifier: NCT02824822 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Genetic Markers of Cardiovascular Disease in Epilepsy

Condition: Epilepsy · Seizures · Syncope  ·  Sponsor: Mayo Clinic

PhaseN/A
Planned participants600
Who can joinAll sexes, 18 Years to 50 Years
Healthy volunteersNo

About this study

Epilepsy is a common condition which affects over 3 million people in the US. Patients with uncontrolled epilepsy have a lifetime risk of sudden unexpected death (SUDEP) of 35%, which is greatest in those under 40 years of age. The exact mechanisms and causes are not understood but can be due to underlying conditions which affect the heart and brain, which may lead to dangerous heart rhythms and death. Some of these conditions which affect heart and brain have an identifiable genetic cause. This study aims to identify known genetic causes of heart rhythm and sudden death related disorders in patients with epilepsy.

This description comes directly from the study's public registry record.

Talk to the study team

Somers CPL Lab  ·  CPL@mayo.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Mayo ClinicRochester, Minnesota, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02824822